Abiraterone

From Libre Pathology
Revision as of 13:10, 18 March 2019 by Michael (talk | contribs) (→‎See also)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Abiraterone is an androgen synthesis inhibitor used to treat prostate cancer.[1]

See also

References

  1. Mitsiades, N. (Aug 2013). "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.". Cancer Res 73 (15): 4599-605. doi:10.1158/0008-5472.CAN-12-4414. PMID 23887973.